Menu
Recruiting NCT07507721

Tele-Nursing-Supported Mindfetalness: Anxiety and Prenatal Attachment

No phase Interventional Tele-nursing Fetal Movement

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Tele-Nursing-Supported Mindfetalness, Mindfetalness Alone.
Who it may be relevant to
Registry conditions: Tele-nursing, Fetal Movement. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Tele-nursing-Supported Mindfetalness Method on Maternal Anxiety and Prenatal Attachment: A Mixed Methods Randomized Controlled Trial

Overview

The goal of this clinical trial is to compare the effects of tele-nursing-supported Mindfetalness method versus Mindfetalness alone method on maternal anxiety and prenatal attachment in pregnant women. The main questions it aims to answer are: * H1: Tele-nursing-supported Mindfetalness method will significantly reduce state anxiety (STAI-S) levels in pregnant women over time compared to Mindfetalness alone method. * H2: Tele-nursing-supported Mindfetalness method will significantly reduce trait anxiety (STAI-T) levels in pregnant women over time compared to Mindfetalness alone method. * H3: Tele-nursing-supported Mindfetalness method will significantly increase prenatal attachment (PAI) levels in pregnant women over time compared to Mindfetalness alone method. Researches will compare tele-nursing-supported Mindfetalness to Mindfetalness alone to see if tele-nursing support significiantly reduces state and trait anxiety levels and significiantly increases prenatal attachment levels in pregnant women over time. Participants will; * Attend a single, face-to-face Mindfetalness training session at the beginning of the study to learn technique and application procedures correctly. * Practice Mindfetalness method daily for 15 minutes throughout the 8-week study period. * Complete a daily compliance tracking chart to record their adherence to the Mindfetalness method of their practice. * Complete the State-Trait Anxiety Inventory (STAI) and the Prenatal Attachment Inventory (PAI) at baseline and during 4th and 8th-week follow-up measurements to track changes over time.

Interventions

  • Behavioral Tele-Nursing-Supported Mindfetalness
    The intervention involves the Mindfetalness method, a subjective practice focused on sensing the quality of fetal movements rather than numerical counting. All participants receive a single, face-to-face training session and are instructed to practice the method for 15 minutes daily throughout the 8-week study period. Adherence is monitored via a daily compliance tracking chart, with photos of the logs submitted to researchers at weeks 4 and 8. Tele-nursing-supported uniquely receives additional
  • Behavioral Mindfetalness Alone
    The intervention involves the Mindfetalness method, a subjective practice focused on sensing the quality of fetal movements rather than numerical counting. All participants receive a single, face-to-face training session and are instructed to practice the method for 15 minutes daily throughout the 8-week study period. Adherence is monitored via a daily compliance tracking chart, with photos of the logs submitted to researchers at weeks 4 and 8.

Primary outcome measures

  • Maternal state anxiety (State-Trait Anxiety Inventory) [Time frame: A repeated measures design will be employed, with data collected at three time points: baseline, week 4, and week 8 to evaluate the intervention's impact over time.]
  • Maternal Trait Anxiety (State-Trait Anxiety Inventory) [Time frame: A repeated measures design will be employed, with data collected at three time points: baseline, week 4, and week 8 to evaluate the intervention's impact over time.]
  • Prenatal Attachment (Prenatal Attachment Inventory) [Time frame: A repeated measures design will be employed, with data collected at three time points: baseline, week 4, and week 8 to evaluate the intervention's impact over time.]
Secondary outcome measures (3)
  • Adherence to the Mindfetalness method (Daily Adherence Log) [Time frame: To verify adherence, participants are required to submit photographs of the completed forms via a secure messaging platform (WhatsApp) at the end of week 4 (first form) and week 8 (second form).]
  • Healthcare Utilization for Perceived Reduced Fetal Movement [Time frame: Hospital admissions will be recorded and evaluated at the end of weeks 4 and 8.]
  • The subjective effects, experiences and satisfaction levels of the intervention among pregnant women (Semi-structured interview form) [Time frame: Qualitative data will be collected at the end of week 8, following the completion of the 8-week intervention and final quantitative assessments.]

Eligibility criteria

Inclusion criteria

  • Aged 18 years or older
  • Being at the 28th week of gestation
  • Having a singleton pregnancy
  • Being primiparous
  • Being literate
  • Having access to and the ability to use a mobile device and internet connection (personal or via spouse) compatible with the tele-nursing application
  • Volunteering to participate in the study and providing informed consent (Araştırmaya katılmaya gönüllü olmak ve bilgilendirilmiş onam vermek)

Exclusion criteria

  • Having a high-risk pregnancy (e.g., preterm labor threat, preeclampsia, gestational diabetes, placenta previa, or cardiac disease).
  • Presence of diagnosed fetal health complications (e.g., intrauterine growth restriction \[IUGR\], fetal anomalies).
  • Currently monitoring fetal movements using any other conventional fetal movement counting methods.
  • Presence of any communication barriers (e.g., hearing, speech, or language impairments).
  • History or current diagnosis of chronic or psychiatric illness.
  • Conception through assisted reproductive techniques (ART) (e.g., IVF).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 2 centers
  • Abant Izzet Baysal University Izzet Baysal Training and Research Hospital — Bolu
  • Bolu Abant Izzet Baysal University — Bolu

Identifiers

NCT: NCT07507721 · AIBU-HEM-BB-03

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗